Tarsons Products Ltd
Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others' including benchtop equipment, used in various laboratories across research organizations, academia institutes, pharmaceutical companies, Contract Research Organizations, Diagnostic companies, and hospitals[1]
- Market Cap ₹ 1,229 Cr.
- Current Price ₹ 231
- High / Low ₹ 465 / 229
- Stock P/E 59.8
- Book Value ₹ 118
- Dividend Yield 0.00 %
- ROCE 6.91 %
- ROE 4.75 %
- Face Value ₹ 2.00
Pros
Cons
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Equipment & Supplies Medical Equipment & Supplies
Part of BSE Healthcare BSE SmallCap BSE Allcap
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 229 | 301 | 296 | 392 | 402 | |
| 125 | 148 | 196 | 282 | 283 | |
| Operating Profit | 103 | 153 | 100 | 111 | 119 |
| OPM % | 45% | 51% | 34% | 28% | 30% |
| 5 | 8 | 11 | 16 | 14 | |
| Interest | 3 | 4 | 10 | 20 | 20 |
| Depreciation | 14 | 22 | 40 | 62 | 80 |
| Profit before tax | 92 | 135 | 61 | 45 | 32 |
| Tax % | 25% | 25% | 30% | 34% | |
| 69 | 101 | 43 | 30 | 21 | |
| EPS in Rs | 3,583.25 | 18.92 | 8.01 | 5.60 | 3.86 |
| Dividend Payout % | 0% | 0% | 25% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 9% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -34% |
| TTM: | -41% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -31% |
| 1 Year: | -42% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 5% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 0.19 | 11 | 11 | 11 | 11 |
| Reserves | 244 | 479 | 602 | 620 | 616 |
| 34 | 22 | 269 | 339 | 396 | |
| 18 | 33 | 90 | 111 | 141 | |
| Total Liabilities | 296 | 544 | 972 | 1,080 | 1,164 |
| 120 | 189 | 336 | 536 | 583 | |
| CWIP | 22 | 32 | 267 | 233 | 251 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| 153 | 323 | 369 | 311 | 330 | |
| Total Assets | 296 | 544 | 972 | 1,080 | 1,164 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 68 | 83 | 103 | 114 | |
| -64 | -138 | -285 | -145 | |
| -27 | 130 | 136 | 39 | |
| Net Cash Flow | -23 | 75 | -47 | 8 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2021 | Mar 2022 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 75 | 79 | 96 | 74 |
| Inventory Days | 277 | 478 | 572 | 355 |
| Days Payable | 35 | 75 | 65 | 44 |
| Cash Conversion Cycle | 317 | 482 | 602 | 385 |
| Working Capital Days | 108 | 150 | -1 | 38 |
| ROCE % | 35% | 7% |
Documents
Announcements
-
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
14 Nov - MUFG sold 1,092,519 shares (2.05%), reducing holdings to 5.28% as of Nov 12, 2025.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Nov - Newspaper Publication for financial results for the second quarter and half year ended September 30, 2025
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
13 Nov - Tarsons uploaded Q2 FY26 earnings call audio recording dated November 13, 2025.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
13 Nov - Investor Presentation for the second quarter and half year ended September, 30, 2025.
-
Results For The Quarter And Half Year Ended September 30, 2025
12 Nov - Board approved unaudited standalone and consolidated Q2/H1 results (ended Sep 30, 2025); limited review by PwC; meeting Nov 12, 2025.
Annual reports
Concalls
-
Nov 2025TranscriptNotesPPT
-
Aug 2025Transcript PPT
-
Jun 2025Transcript PPT REC
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT REC
-
Aug 2024TranscriptNotesPPT
-
Jun 2024Transcript PPT
-
Feb 2024Transcript PPT REC
-
Feb 2024TranscriptNotesPPT
-
Dec 2023TranscriptPPTREC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT
-
Jun 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
India’s Leading Labware Company[1]
One of the leading Indian labware company engaged in designing, development, manufacturing and marketing of consumables, reusables and others (including benchtop
equipment & instruments)